How to Lose Fat: Peptides, Supplements & Biomarkers Guide

The short version

Sustainable fat loss in 2026 is a metabolic intervention, not a willpower test. The compounds that actually move the needle — semaglutide, tirzepatide, retatrutide — work by recalibrating insulin sensitivity, satiety, and inflammation. The supplements that pair with them prevent the muscle loss and nutrient deficiencies that derail most cuts. The biomarkers tell you whether the protocol is producing real metabolic improvement or just scale movement.

Why this protocol works

GLP-1 receptor agonists drove a 15–22% body-weight reduction across the STEP and SURMOUNT trials, but the published data also showed 25–40% of weight lost was lean mass in participants without structured resistance training and adequate protein. Pairing the medication with a recovery-supportive supplement stack — magnesium, B12, fish oil, electrolytes — addresses the most-cited deficiencies that show up after 3–6 months on these compounds.

The biomarkers that matter for fat loss are NOT body weight or BMI — those move for the wrong reasons (water, muscle). ApoB shows whether your cardiovascular risk is improving. HbA1c shows whether insulin sensitivity is recovering. Liver enzymes show whether visceral fat is resolving. Fasting insulin shows the recovery curve faster than HbA1c.

Peptides commonly used for lose fat

Supplement stack pairing

Biomarkers to track for lose fat

The protocol

1. 1
   Pull a baseline panel BEFORE starting: fasting insulin, HbA1c, full lipid panel including ApoB, hs-CRP, liver enzymes (ALT/AST/GGT). Without baseline, you cannot prove the protocol worked.
2. 2
   Start with the lowest medication titration step. GI side effects are dose-dependent and most users underestimate the slow ramp the trials used.
3. 3
   Eat protein. Target ≥1g/kg bodyweight (research-cited threshold for muscle preservation during caloric restriction). Most users on GLP-1 dramatically under-eat protein because total appetite is suppressed.
4. 4
   Resistance train 2–3x/week. Lean mass loss is not inevitable; the trials that combined GLP-1 with structured training showed roughly half the lean mass loss.
5. 5
   Re-test labs at 12 weeks. ApoB and HbA1c should both be moving down. Liver enzymes should be falling. If they are not, the protocol needs adjustment with your provider.

Common pitfalls

• ×Skipping baseline labs — without them, every "is it working?" question is a guess.
• ×Ignoring electrolytes. GLP-1 medications + reduced food = real sodium/magnesium loss. Cramping, headaches, and fatigue are usually electrolyte issues, not the medication.
• ×Not tracking ApoB. Standard lipid panels include LDL-C, which can read normal while ApoB is still elevated. ApoB is the better cardiovascular risk marker — order it specifically.
• ×Tracking weight daily. Water weight masks fat loss for weeks at a time. Weekly average + body composition checks every 4–6 weeks gives a clearer signal.

Other goals